BJ’s Restaurants, Inc. (NASDAQ: BJRI) Board of Directors member Noah Elbogen sold 7,535 shares of common stock on August 10, 2026, according to a recent SEC Form 4 filing.
The shares were disposed of at a weighted average sale price of $70.14 per share, generating a total transaction value of approximately $529,000.
The sale reduced Elbogen’s direct equity holdings in the company by 10%, a notable but not dramatic reduction in his overall position.
Following the transaction, Elbogen retains direct ownership of 71,655 shares, valued at approximately $4.92 million based on the August 10, 2026 market close price of $68.65.
The director also holds derivative securities, including 2,955 unvested restricted stock units, meaning his financial exposure to the company’s performance remains substantial.
The timing of the sale is notable, coming shortly after BJRI shares hit a 52-week high of $74.60 on July 30, 2026, just days before the transaction was executed.
With the stock delivering a 104% one-year total return leading up to the sale, Elbogen’s decision to lock in gains on a portion of his holdings appears strategically timed.
As of the August 11, 2026 market close, BJRI shares were trading at $67.53, meaning Elbogen executed his sale above the prevailing market price at $70.14 per share.
BJ’s Restaurants reported strong second-quarter results, generating $388.9 million in revenue, representing a 6% year-over-year increase that helped drive the stock’s appreciation.
Same-store sales jumped 6.5% year over year during the quarter, a performance strong enough to prompt the company to raise its full-year financial guidance.
The company also repurchased and retired 64,000 shares during the period, a move that contributed to upward pressure on the share price throughout the year.
BJ’s Restaurants operates approximately 213 casual dining restaurants across 29 states, offering a menu that includes pizzas, craft beers, appetizers, pasta dishes, sandwiches, salads, and desserts.
The company carries a market capitalisation of $1.4 billion, with trailing 12-month revenue of $1.4 billion and net income of $40.9 million, supported by roughly 22,230 employees.
While insider sales can sometimes signal concern about near-term prospects, Elbogen’s decision to retain more than 71,000 shares suggests continued confidence in the company’s trajectory and alignment with broader shareholder interests.
